Clinical Trial Update: Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating IgG-enriched immunotherapy to modulate the gut-liver axis in severe alcohol-associated hepatitis; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• IgG-enriched immunotherapy

Snippet

Sponsor: Dayanand Medical College and Hospital | Conditions: Alcoholic Hepatitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING